Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar

BACKGROUND: Plasmodium falciparum resistance to artemisinins, the first line treatment for malaria worldwide, has been reported in western Cambodia. Resistance is characterized by significantly delayed clearance of parasites following artemisinin treatment. Artemisinin resistance has not previously...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Kyaw, M, Nyunt, M, Chit, K, Aye, M, Aye, K, Lindegardh, N, Tarning, J, Imwong, M, Jacob, C, Rasmussen, C, Perin, J, Ringwald, P
Formato:	Journal article
Idioma:	English
Publicado em:	Public Library of Science 2013

Registros relacionados

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
por: Myat P Kyaw, et al.
Publicado em: (2013-01-01)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
por: Das, J, et al.
Publicado em: (2018)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
por: Jesmin Permala Lohy Das, et al.
Publicado em: (2018-03-01)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
por: Hien, T, et al.
Publicado em: (2012)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
por: Hien, T, et al.
Publicado em: (2012)

Characterization of Trichoderma species Isolated from Different Ecosystems in Myanmar
por: Khin Maung Nyunt, et al.
Publicado em: (2020-03-01)

Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar
por: Than Naing Soe, et al.
Publicado em: (2017-07-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
por: Smithuis, F, et al.
Publicado em: (2006)

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.
por: Htun, M, et al.
Publicado em: (2017)

<it>In vivo</it> susceptibility of <it>Plasmodium falciparum</it> to artesunate in Binh Phuoc Province, Vietnam
por: Hien Tran, et al.
Publicado em: (2012-10-01)

Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009–2013)
por: Myat Htut Nyunt, et al.
Publicado em: (2017-08-01)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
por: Win, AA, et al.
Publicado em: (2016)

Seroprevalence of toxoplasmosis among reproductive-aged women in Myanmar and evaluation of luciferase immunoprecipitation system assay
por: Khin Myo Aye, et al.
Publicado em: (2020-11-01)

The legend of laphet: A Myanmar fermented tea leaf
por: Thazin Han, et al.
Publicado em: (2015-12-01)

Overview of pediatric oncology and hematology in Myanmar
por: Jay Halbert, et al.
Publicado em: (2014-01-01)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
por: Das, D, et al.
Publicado em: (2013)

Myanmar in Asean : Myanmar-Asean cooperation for development.
por: Hnin Hnin Aye.
Publicado em: (2008)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
por: Jamsen, K, et al.
Publicado em: (2011)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
por: Thu Zar Han, et al.
Publicado em: (2017-08-01)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
por: Valea, I, et al.
Publicado em: (2014)

No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
por: Fang Huang, et al.
Publicado em: (2020-09-01)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
por: Awab, GR, et al.
Publicado em: (2016)

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
por: Smithuis, F, et al.
Publicado em: (2004)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
por: Han, T.Z., et al.
Publicado em: (2017)

Residual malaria among migrant workers in Myanmar: why still persistent and how to eliminate it?
por: Myat Htut Nyunt, et al.
Publicado em: (2021-11-01)

Artemisinin resistance in Plasmodium falciparum malaria.
por: Dondorp, A, et al.
Publicado em: (2009)

Spectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia—A First Report from Myanmar
por: Than Than Aye, et al.
Publicado em: (2025-02-01)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Lindegardh Niklas, et al.
Publicado em: (2011-07-01)

Women's intergenerational intimate partner violence and household child abuse in Burma (Myanmar)
por: Stephanie Spaid Miedema, et al.
Publicado em: (2022-03-01)

Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis
por: Aung Chan Minn, et al.
Publicado em: (2018-01-01)

Myanmar Number Normalization for Text-to-Speech
por: Aye Mya Hlaing, et al.
Publicado em: (2022-08-01)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
por: Mcgready, R, et al.
Publicado em: (2008)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria
por: Singhasivanon Pratap, et al.
Publicado em: (2009-09-01)

391 Health status of children with down syndrome in Myanmar
por: Kyaw Linn, et al.
Publicado em: (2021-04-01)

Active surveillance for congenital rubella syndrome in Yangon, Myanmar
por: Thant Kyaw-Zin, et al.
Publicado em: (2006-01-01)

Distribution of hepatitis B virus genotypes in the general population of Myanmar via nationwide study
por: Yi Yi Kyaw, et al.
Publicado em: (2020-07-01)

Malaria incidence in Myanmar 2005–2014: steady but fragile progress towards elimination
por: Thet Thet Mu, et al.
Publicado em: (2016-10-01)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
por: Ambler, M, et al.
Publicado em: (2009)

Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022
por: Phyu Win Ei, et al.
Publicado em: (2025-03-01)

Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
por: Guthmann, J, et al.
Publicado em: (2008)